General Report

Neurodevelopmental disorder with spastic diplegia and visual defects by CTNNB1 gene mutation: a report of 5 Chinese cases with literature review

  • Kexin PANG ,
  • Pei WANG ,
  • Min ZHU ,
  • Fen LU ,
  • Jian TANG ,
  • Li ZHANG
Expand
  • Department of Rehabilitation, Children's Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu, China

Received date: 2021-10-11

  Online published: 2022-08-09

Abstract

Objective To investigate the clinical characteristics and genetic variants of children with neurodevelopmental disorder with spastic diplegia and visual defects (NEDSDV). Methods A retrospective analysis was performed on the clinical manifestations, laboratory examinations, and genetic testing of 5 NEDSDV children diagnosed in the rehabilitation department of Nanjing Children's Hospital from 2014 to 2020, and the clinical manifestations and genetic characteristics of the patients were summarized together with literature review. Results All the five patients showed features of global developmental delay, microcephaly and spastic diplegia. Among them, patients 1, 2, 3, and 5 all had strabismus, and patient 5 had severe congenital retinal exudative abnormalities. Genetic testing identified de novo heterozygous mutations of CTNNB1 gene in all of the five patients, and all of them were truncated mutations (including nonsense and frameshift mutations), of which c.478_479insTAAATGA, c.1973dupT and c.625G>T were newly discovered mutations. Compared with 39 cases of genetically diagnosed patients reported abroad from 2001 to 2020 (including 5 adult cases), all but one child in this study had a slightly thinner corpus callosum, the other four cases showed no significant brain imaging abnormalities, and retinopathy was relatively rare. Conclusions Global developmental delay accompanied by microcephaly and spastic diplegia can be an indication for the suspected diagnosis of NEDSDV, while ocular lesions and brain imaging abnormalities are not necessary phenotypes for clinical diagnosis, and confirmation of diagnosis depends on genetic testing. The identification of three novel variants of CTNNB1 expands the pathogenic variants spectrum of NEDSDV.

Cite this article

Kexin PANG , Pei WANG , Min ZHU , Fen LU , Jian TANG , Li ZHANG . Neurodevelopmental disorder with spastic diplegia and visual defects by CTNNB1 gene mutation: a report of 5 Chinese cases with literature review[J]. Journal of Clinical Pediatrics, 2022 , 40(8) : 616 -622 . DOI: 10.12372/jcp.2022.21e1421

References

[1] de Ligt J, Willemsen MH, van Bon BW, et al. Diagnostic exome sequencing in persons with severe intellectual disability[J]. N Engl J Med, 2012, 367(20): 1921-1929.
[2] Kuechler A, Willemsen MH, Albrecht B, et al. De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum[J]. Hum Genet, 2015, 134(1): 97-109.
[3] Ke Z, Chen Y. Case report: a de novo CTNNB1 nonsense mutation associated with neurodevelopmental disorder, retinal detachment, polydactyly[J]. Front Pediatr, 2020, 8: 575673.
[4] Verhoeven WMA, Egger JIM, Jongbloed RE, et al. A de novo CTNNB1 novel splice variant in an adult female with severe intellectual disability[J]. Int Med Case Rep J, 2020, 13: 487-492.
[5] Winczewska-Wiktor A, Badura-Stronka M, Monies-Nowicka A, et al. A de novo CTNNB1 nonsense mutation associated with syndromic atypical hyperekplexia, microcephaly and intellectual disability: a case report[J]. BMC Neurol, 2016, 16: 35.
[6] Kharbanda M, Pilz DT, Tomkins S, et al. Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals[J]. Eur J Med Genet, 2017, 60(2): 130-135.
[7] Takezawa Y, Kikuchi A, Haginoya K, et al. Genomic analysis identifies masqueraders of full-term cerebral palsy[J]. Ann Clin Transl Neurol, 2018, 5(5): 538-551.
[8] Yan R, Liu P, Li F, et al. Generation of a human induced pluripotent stem cell line (SBWCHi001-A) from a patient with NEDSDV carrying a pathogenic mutation in CTNNB1 gene[J]. Stem Cell Res, 2020, 49: 102091.
[9] Wang H, Zhao Y, Yang L, et al. Identification of a novel splice mutation in CTNNB1 gene in a Chinese family with both severe intellectual disability and serious visual defects[J]. Neurol Sci, 2019, 40(8): 1701-1704.
[10] Li N, Xu Y, Li G, et al. Exome sequencing identifies a de novo mutation of CTNNB1 gene in a patient mainly presented with retinal detachment, lens and vitreous opacities, microcephaly, and developmental delay: case report and literature review[J]. Medicine (Baltimore), 2017, 96(20): e6914.
[11] Jin SC, Lewis SA, Bakhtiari S, et al. Mutations disrupting neuritogenesis genes confer risk for cerebral palsy[J]. Nat Genet, 2020, 52(10): 1046-1056.
[12] Dixon MW, Stem MS, Schuette JL, et al. CTNNB1 mutation associated with familial exudative vitreoretinopathy (FEVR) phenotype[J]. Ophthalmic Genet, 2016, 37(4): 468-470.
[13] Coussa RG, Zhao Y, DeBenedictis MJ, et al. Novel mutation in CTNNB1 causes familial exudative vitreoretinopathy (FEVR) and microcephaly: case report and review of the literature[J]. Ophthalmic Genet, 2020, 41(1): 63-68.
[14] Panagiotou ES, Sanjurjo Soriano C, Poulter JA, et al. Defects in the Cell Signaling Mediator beta-Catenin Cause the Retinal Vascular Condition FEVR[J]. Am J Hum Genet, 2017, 100(6): 960-968.
[15] Zhu X, Yang M, Zhao P, et al. Catenin alpha 1 mutations cause familial exudative vitreoretinopathy by overactivating Norrin/beta-catenin signaling[J]. J Clin Invest, 2021, 131(6): e139869.
[16] Sun W, Xiao X, Li S, et al. Germline mutations in CTNNB1 associated with syndromic FEVR or norrie disease[J]. Invest Ophthalmol Vis Sci, 2019, 60(1): 93-97.
[17] Dong F, Jiang J, McSweeney C, et al. Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defects[J]. Hum Mol Genet, 2016, 25(13): 2738-2751.
[18] Tucci V, Kleefstra T, Hardy A, et al. Dominant beta-catenin mutations cause intellectual disability with recognizable syndromic features[J]. J Clin Invest, 2014, 124(4): 1468-1482.
[19] Brault V, Moore R, Kutsch S, et al. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development[J]. Development, 2001, 128(8): 1253-1264.
Outlines

/